Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 6,765,700 shares, a decrease of 6.6% from the December 15th total of 7,246,500 shares. Based on an average daily trading volume, of 1,464,200 shares, the days-to-cover ratio is presently 4.6 days.
Curaleaf Price Performance
Curaleaf stock opened at $1.51 on Monday. The firm has a market cap of $981.33 million, a P/E ratio of -5.21 and a beta of 0.64. The stock’s 50 day moving average is $1.72 and its 200 day moving average is $2.72. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.11 and a quick ratio of 0.51. Curaleaf has a one year low of $0.88 and a one year high of $6.40.
Analyst Ratings Changes
Several equities research analysts recently commented on CURLF shares. Roth Capital upgraded shares of Curaleaf to a “strong-buy” rating in a research report on Sunday, November 10th. Cormark lowered shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday, November 7th.
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
See Also
- Five stocks we like better than Curaleaf
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What to Know About Investing in Penny Stocks
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Technology Stocks Explained: Here’s What to Know About Tech
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.